However, whereas all control mice orally exposed to prions at 21 days old succumbed to clinical prion disease, those with LI FDC-containing GALT only at the time of exposure displayed dramatically reduced disease susceptibility (21-day-old LTβR-Ig-treated mice). This evidence concerns the gene GALT and prion disease.